It’s estimated that more than half of people diagnosed with lung cancer lose their battle within the first year. This statistic is alarming, especially for RCCA patients and their families who are currently dealing with lung cancer. Despite advancements in science, lung cancer remains one of the most common—and lethal—types of cancer worldwide.
For years, lung cancer has been one of the leading killers among cancers in the United States for both men and women. Let’s take a look at some of the data.
One reason why the survival rate for lung cancer is so low is a lack of early detection. Unfortunately, most patients do not experience symptoms of lung cancer at first. They feel healthy and have no need to visit a doctor, even while a tumor is growing in their chest. It’s not until later, when the disease has progressed, that they start coughing and feel sick.
The later someone is diagnosed with any type of cancer, the lower the chances of survival. And since only 16% of lung cancer cases are diagnosed at an early stage, one can see why so many people lose their fight. As cancer progresses, it starts to spread to other parts of the body, making it more difficult to treat.
Treatment depends on the type of lung cancer, the stage that it’s in and the person’s health. The most common options include radiation therapy, chemotherapy, targeted therapy, immunotherapy and clinical trials.
If the cancer is only in one lung and has not spread anywhere else, surgery may also be an option. But lung transplants are usually not recommended. Once the cancer spreads, a transplant won’t be effective.
At RCCA, we work tirelessly to make sure every patient receives the care he or she deserves.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.